187 related articles for article (PubMed ID: 38671086)
1. Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas.
Elbert M; Neumann F; Kiefer M; Christofyllakis K; Balensiefer B; Kos I; Carbon G; Kaddu-Mulindwa D; Bittenbring JT; Fadle N; Regitz E; Fend F; Bonzheim I; Thurner L; Bewarder M
Sci Rep; 2024 Apr; 14(1):9571. PubMed ID: 38671086
[TBL] [Abstract][Full Text] [Related]
2. Hyper-
Thurner L; Preuss KD; Bewarder M; Kemele M; Fadle N; Regitz E; Altmeyer S; Schormann C; Poeschel V; Ziepert M; Walter S; Roth P; Weller M; Szczepanowski M; Klapper W; Monoranu C; Rosenwald A; Möller P; Hartmann S; Hansmann ML; Mackensen A; Schäfer H; Schorb E; Illerhaus G; Buslei R; Bohle RM; Stilgenbauer S; Kim YJ; Pfreundschuh M
Blood; 2018 Dec; 132(26):2744-2753. PubMed ID: 30249786
[TBL] [Abstract][Full Text] [Related]
3. Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma.
Bewarder M; Kiefer M; Moelle C; Goerens L; Stilgenbauer S; Christofyllakis K; Kaddu-Mulindwa D; Fadle N; Regitz E; Neumann F; Hoth M; Preuss KD; Pfreundschuh M; Thurner L
Front Oncol; 2020; 10():580364. PubMed ID: 33282736
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of primary vitreoretinal lymphoma.
Arai A; Takase H; Yoshimori M; Yamamoto K; Mochizuki M; Miura O
Cancer Sci; 2020 Apr; 111(4):1417-1421. PubMed ID: 32056332
[TBL] [Abstract][Full Text] [Related]
5. Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens.
Young RM; Wu T; Schmitz R; Dawood M; Xiao W; Phelan JD; Xu W; Menard L; Meffre E; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza LM; Staudt LM
Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13447-54. PubMed ID: 26483459
[TBL] [Abstract][Full Text] [Related]
6. [Molecular diagnostics for vitreoretinal lymphoma].
Bonzheim I; Salmerón-Villalobos J; Süsskind D; Szurman P; Gekeler F; Spitzer MS; Salaverria I; Campo E; Coupland SE; Quintanilla-Martinez L; Fend F
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):150-154. PubMed ID: 37947807
[TBL] [Abstract][Full Text] [Related]
7. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.
Chan CC; Rubenstein JL; Coupland SE; Davis JL; Harbour JW; Johnston PB; Cassoux N; Touitou V; Smith JR; Batchelor TT; Pulido JS
Oncologist; 2011; 16(11):1589-99. PubMed ID: 22045784
[TBL] [Abstract][Full Text] [Related]
8. Primary vitreoretinal lymphomas display a remarkably restricted immunoglobulin gene repertoire.
Belhouachi N; Xochelli A; Boudjoghra M; Lesty C; Cassoux N; Fardeau C; Tran THC; Choquet S; Sarker B; Houillier C; Alentorn A; LeHoang P; Soussain C; Touitou V; Merle-Beral H; Hoang-Xuan K; Bodaghi B; Stamatopoulos K; Davi F
Blood Adv; 2020 Apr; 4(7):1357-1366. PubMed ID: 32267931
[TBL] [Abstract][Full Text] [Related]
9. Molecular biomarkers for the diagnosis of primary vitreoretinal lymphoma.
Wang Y; Shen D; Wang VM; Sen HN; Chan CC
Int J Mol Sci; 2011; 12(9):5684-97. PubMed ID: 22016619
[TBL] [Abstract][Full Text] [Related]
10. IL-10 -1082 SNP and IL-10 in primary CNS and vitreoretinal lymphomas.
Ramkumar HL; Shen DF; Tuo J; Braziel RM; Coupland SE; Smith JR; Chan CC
Graefes Arch Clin Exp Ophthalmol; 2012 Oct; 250(10):1541-8. PubMed ID: 22628023
[TBL] [Abstract][Full Text] [Related]
11. An unusual case report of primary vitreoretinal lymphoma.
Tan SZ; Steeples LR; Chhabra R; Jones NP
BMC Ophthalmol; 2018 Sep; 18(Suppl 1):223. PubMed ID: 30255824
[TBL] [Abstract][Full Text] [Related]
12. Two cases of primary vitreoretinal lymphoma: a diagnostic challenge : The supporting role of multimodal imaging in the diagnosis of primary vitreoretinal lymphoma.
Morara M; Foschi F; Veronese C; Torrazza C; Bacci F; Stefoni V; Ciardella PA
Int Ophthalmol; 2018 Feb; 38(1):353-361. PubMed ID: 28039672
[TBL] [Abstract][Full Text] [Related]
13. CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential.
Yonese I; Takase H; Yoshimori M; Onozawa E; Tsuzura A; Miki T; Mochizuki M; Miura O; Arai A
Eur J Haematol; 2019 Feb; 102(2):191-196. PubMed ID: 30390359
[TBL] [Abstract][Full Text] [Related]
14. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.
Castellino A; Pulido JS; Johnston PB; Ristow KM; Nora Bennani N; Inwards DJ; Macon WR; Micallef INM; King RL; Salomao DR; Witzig TE; Habermann TM; Nowakowski GS
Am J Hematol; 2019 Mar; 94(3):291-298. PubMed ID: 30516868
[TBL] [Abstract][Full Text] [Related]
15. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
[TBL] [Abstract][Full Text] [Related]
16. Primary vitreoretinal lymphoma: a diagnostic and management challenge.
Soussain C; Malaise D; Cassoux N
Blood; 2021 Oct; 138(17):1519-1534. PubMed ID: 34036310
[TBL] [Abstract][Full Text] [Related]
17. Characteristic optical coherence tomography findings in patients with primary vitreoretinal lymphoma: a novel aid to early diagnosis.
Barry RJ; Tasiopoulou A; Murray PI; Patel PJ; Sagoo MS; Denniston AK; Keane PA
Br J Ophthalmol; 2018 Oct; 102(10):1362-1366. PubMed ID: 29306864
[TBL] [Abstract][Full Text] [Related]
18. Primary vitreoretinal lymphoma.
Mulay K; Narula R; Honavar SG
Indian J Ophthalmol; 2015 Mar; 63(3):180-6. PubMed ID: 25971162
[TBL] [Abstract][Full Text] [Related]
19. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
[TBL] [Abstract][Full Text] [Related]
20. Role of Specific B-Cell Receptor Antigens in Lymphomagenesis.
Thurner L; Hartmann S; Neumann F; Hoth M; Stilgenbauer S; Küppers R; Preuss KD; Bewarder M
Front Oncol; 2020; 10():604685. PubMed ID: 33363034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
